Suchergebnisse - "Perez-Fidalgo, J Alejandro"

PubPharm (23)

1

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Jhaveri, K. | Bellet, M. | Turner, N. | +19

2

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

3

Systemic treatment of newly diagnosed advanced epithelial ovarian cancer : From chemotherapy to precision medicine

enthalten in: Critical reviews in oncology/hematology | 2021

von Perez-Fidalgo, J. | Grau, F. | Fariñas, L. | +1

4

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

enthalten in: Breast cancer research : BCR | 2021

von Schmid, P. | Sablin, M. | Bergh, J. | +17

5

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

enthalten in: Breast cancer research | 2021

von Schmid, P. | Sablin, M. | Bergh, J. | +17

6

Endometriosis-associated ovarian carcinomas : insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review

enthalten in: Annals of translational medicine | 2020

von Samartzis, E. | Labidi-Galy, S. | Moschetta, M. | +4

7

Aurora kinases in ovarian cancer

enthalten in: ESMO open | 2020

von Pérez-Fidalgo, J. | Gambardella, V. | Pineda, B. | +3

8

Cell proliferation inhibitors and apoptosis promoters

enthalten in: EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al. | 2020

von Perez-Fidalgo, J.

9

Immunotherapies in ovarian cancer

enthalten in: EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al. | 2020

von García-Martínez, E. | Pérez-Fidalgo, J.

10

Correction : ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Guerrero-Zotano, A. | Stricker, T. | Formisano, L. | +19

ErratumFor: Clin Cancer Res. 2018 Jun 1;24(11):2517-2529. - PMID 29581135